Integral Ad Science’s (IAS) Equal Weight Rating Reiterated at Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Integral Ad Science (NASDAQ:IAS) in a research note released on Tuesday, Marketbeat.com reports. The brokerage currently has a $12.00 price target on the stock, down from their prior price target of $18.00.

A number of other research analysts also recently weighed in on the stock. Oppenheimer decreased their price objective on shares of Integral Ad Science from $25.00 to $20.00 and set an outperform rating for the company in a research report on Wednesday, February 28th. Barclays decreased their price objective on shares of Integral Ad Science from $16.00 to $12.00 and set an equal weight rating for the company in a research report on Monday. BMO Capital Markets decreased their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a research report on Wednesday, February 28th. Bank of America began coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They issued a buy rating and a $19.00 price objective for the company. Finally, Truist Financial decreased their price objective on shares of Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research report on Wednesday, February 28th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Integral Ad Science has an average rating of Moderate Buy and a consensus target price of $17.58.

Integral Ad Science Price Performance

NASDAQ:IAS opened at $9.53 on Tuesday. Integral Ad Science has a one year low of $9.10 and a one year high of $20.88. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21. The firm has a market cap of $1.52 billion, a price-to-earnings ratio of 238.31, a PEG ratio of 1.71 and a beta of 1.60. The firm’s fifty day moving average is $11.69 and its two-hundred day moving average is $13.10.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. The company had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The firm’s revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.07 earnings per share. Research analysts expect that Integral Ad Science will post 0.16 EPS for the current year.

Insider Buying and Selling

In related news, CFO Tania Secor sold 17,999 shares of the company’s stock in a transaction dated Monday, April 8th. The shares were sold at an average price of $10.05, for a total transaction of $180,889.95. Following the completion of the transaction, the chief financial officer now owns 239,174 shares in the company, valued at approximately $2,403,698.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CFO Tania Secor sold 17,999 shares of the company’s stock in a transaction dated Monday, April 8th. The shares were sold at an average price of $10.05, for a total transaction of $180,889.95. Following the completion of the sale, the chief financial officer now owns 239,174 shares of the company’s stock, valued at approximately $2,403,698.70. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CAO Alexis Gil II sold 3,177 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the sale, the chief accounting officer now directly owns 120,195 shares of the company’s stock, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock worth $876,562 in the last 90 days. Insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

Several large investors have recently bought and sold shares of the business. Richelieu Gestion SA grew its stake in Integral Ad Science by 35.0% during the 1st quarter. Richelieu Gestion SA now owns 19,501 shares of the company’s stock valued at $194,000 after acquiring an additional 5,055 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Integral Ad Science in the 4th quarter valued at approximately $3,159,000. HBK Investments L P purchased a new stake in shares of Integral Ad Science in the 4th quarter valued at approximately $4,317,000. Vanguard Group Inc. grew its stake in shares of Integral Ad Science by 10.7% in the 4th quarter. Vanguard Group Inc. now owns 8,106,247 shares of the company’s stock valued at $116,649,000 after buying an additional 780,469 shares during the period. Finally, Goldman Sachs Group Inc. grew its stake in shares of Integral Ad Science by 605.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock valued at $39,429,000 after buying an additional 2,351,414 shares during the period. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.